Danh mục tài liệu
Nạp tiền Tải xuống 0

Tất cả tài liệu

Sắp xếp:
  • Mới nhất
  • Xem nhiều nhất
  • Tải nhiều nhất

Neoadjuvant chemotherapy and radiotherapy followed by resection/ ablation in stage IV rectal cancer patients with potentially resectable metastases

Neoadjuvant chemotherapy and radiotherapy followed by resection/ ablation in stage IV rectal cancer patients with potentially resectable metastases

10 0 0
10 trang
Neoadjuvant chemotherapy and radiotherapy followed by resection/ ablation in stage IV rectal cancer patients with potentially resectable metastases

Neoadjuvant chemotherapy and radiotherapy followed by resection/ ablation in stage IV rectal cancer patients with potentially resectable metastases

10 0 0
10 trang
Neoadjuvant chemotherapy and radiotherapy followed by resection/ ablation in stage IV rectal cancer patients with potentially resectable metastases

Neoadjuvant chemotherapy and radiotherapy followed by resection/ ablation in stage IV rectal cancer patients with potentially resectable metastases

10 0 0
10 trang
Neoadjuvant chemotherapy and radiotherapy followed by resection/ ablation in stage IV rectal cancer patients with potentially resectable metastases

Neoadjuvant chemotherapy and radiotherapy followed by resection/ ablation in stage IV rectal cancer patients with potentially resectable metastases

10 0 0
10 trang
Effects of an oral mucosa protective formulation on chemotherapy- and/ or radiotherapy-induced oral mucositis: A prospective study

Effects of an oral mucosa protective formulation on chemotherapy- and/ or radiotherapy-induced oral mucositis: A prospective study

28 0 0
9 trang
Effects of an oral mucosa protective formulation on chemotherapy- and/ or radiotherapy-induced oral mucositis: A prospective study

Effects of an oral mucosa protective formulation on chemotherapy- and/ or radiotherapy-induced oral mucositis: A prospective study

28 0 0
9 trang
Effects of an oral mucosa protective formulation on chemotherapy- and/ or radiotherapy-induced oral mucositis: A prospective study

Effects of an oral mucosa protective formulation on chemotherapy- and/ or radiotherapy-induced oral mucositis: A prospective study

28 0 0
9 trang
Effects of an oral mucosa protective formulation on chemotherapy- and/ or radiotherapy-induced oral mucositis: A prospective study

Effects of an oral mucosa protective formulation on chemotherapy- and/ or radiotherapy-induced oral mucositis: A prospective study

28 0 0
9 trang
Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature

Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature

17 0 0
13 trang
Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature

Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature

17 0 0
13 trang
Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature

Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature

17 0 0
13 trang
Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature

Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature

17 0 0
13 trang
Effectiveness and safety of pegylated liposomal doxorubicin versus epirubicin as neoadjuvant or adjuvant chemotherapy for breast cancer: A real-world study

Effectiveness and safety of pegylated liposomal doxorubicin versus epirubicin as neoadjuvant or adjuvant chemotherapy for breast cancer: A real-world study

6 0 0
11 trang
Effectiveness and safety of pegylated liposomal doxorubicin versus epirubicin as neoadjuvant or adjuvant chemotherapy for breast cancer: A real-world study

Effectiveness and safety of pegylated liposomal doxorubicin versus epirubicin as neoadjuvant or adjuvant chemotherapy for breast cancer: A real-world study

6 0 0
11 trang
Effectiveness and safety of pegylated liposomal doxorubicin versus epirubicin as neoadjuvant or adjuvant chemotherapy for breast cancer: A real-world study

Effectiveness and safety of pegylated liposomal doxorubicin versus epirubicin as neoadjuvant or adjuvant chemotherapy for breast cancer: A real-world study

6 0 0
11 trang
Effectiveness and safety of pegylated liposomal doxorubicin versus epirubicin as neoadjuvant or adjuvant chemotherapy for breast cancer: A real-world study

Effectiveness and safety of pegylated liposomal doxorubicin versus epirubicin as neoadjuvant or adjuvant chemotherapy for breast cancer: A real-world study

6 0 0
11 trang
Aberrant expression of CD54 detected by flow cytometry is a characteristic of B-lymphoma cells in bone marrow specimens

Aberrant expression of CD54 detected by flow cytometry is a characteristic of B-lymphoma cells in bone marrow specimens

10 0 0
9 trang
Aberrant expression of CD54 detected by flow cytometry is a characteristic of B-lymphoma cells in bone marrow specimens

Aberrant expression of CD54 detected by flow cytometry is a characteristic of B-lymphoma cells in bone marrow specimens

10 0 0
9 trang